Infliximab for Refractory Cardiac Sarcoidosis

Harper, LJ; McCarthy, M; Neto, MLR; Hachamovitch, R; Pearson, K; Bonanno, B; Shaia, J; Brunken, R; Joyce, E; Culver, DA

Harper, LJ (reprint author), Cleveland Clin, Dept Pulm Med, Resp Inst, Cleveland, OH 44106 USA.

AMERICAN JOURNAL OF CARDIOLOGY, 2019; 124 (10): 1630

Abstract

Cardiac sarcoidosis (CS) is frequently difficult to treat. Infliximab (IFX) is useful for extracardiac sarcoidosis, but its use in CS has been limited......

Full Text Link